ArticlePeerJ2026

ERO1A as a novel biomarker for risk stratification and immunotherapeutic guidance in early-stage lung adenocarcinoma.

Wangyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.